S&P 500, NASDAQ HOVER NEAR RECORD HIGHS AT OPEN

U.S. retail sales rose at slower-than-expected pace in May amid high interest rates, inflation

GILD Jun 2024 74.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.0700

0.0000

(0.00%)

As of 03:54PM EDT. Market open.

Investor's Business Daily
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
Gilead stock reversed lower Monday after confirming it's testing a popular weight-loss mechanism as a treatment for a liver disease.
Investor's Business Daily
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.
Barrons.com
Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
Gilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game. GLP-1s, the technical name for the popular obesity drugs, has been one of the biggest drivers of pharmaceutical stocks in recent months. Which may be why Gilead stock has gained 2.8% to $64.55 in afternoon trading Friday after Jefferies released a note late Thursday night.